newsfilter
← Latest News
GlobeNewswire·

Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of